Elevance Health is seeing stronger momentum in its Medicaid business after states raised reimbursement rates in July. The company says the rate increases were a positive development for the insurer during the third quarter.
As a result, Elevance now expects its full-year Medicaid margin to be better than the negative 1.75% it previously projected. That revised outlook reflects an improved picture for a segment that has faced cost pressure across the industry.
The report is based on a single source, so there are no conflicting accounts to compare. Still, the shift points to how state funding decisions can directly influence insurer performance in public health programs.